Erratum to atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling
Erratum to: Transl Cancer Res 2020;9:1439-47
In the March 2020 issue of Translational Cancer Research, the paper titled “Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling”, edited by Cai et al. (1), was published with some errors in Figure 6A, Figure 6C and the figure legend. In Figure 6A, for the concentration of 10−5 M, the picture of 0 h was carelessly and incorrectly used. In Figure 6C, for the time point of 0 h, the picture of 10−5 M was carelessly and incorrectly used. In the legend, the description “wound healing assay was performed (A and B)” should be revised to “wound healing assay was performed (A,C)” as A and C depict the wound healing assay, while B and D show statistical analysis. The whole Figure 6 and the figure legends should be corrected as below:
The authors apologize for this error, and state that this does not affect the scientific conclusions of the article.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Cai S, Chen Q, Xu Y, et al. Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling. Transl Cancer Res 2020;9:1439-47. [Crossref] [PubMed]
